Being part of a genetically diverse South Africa means recognising that our differences are not obstacles to be managed, but powerful lenses through which we can better understand health and disease. Professor Michael Pepper, Director of the Institute for Cellular and Molecular Medicine at the University of Pretoria, notes that South Africa is uniquely positioned to address this gap.
A patient arrives at a public clinic in Gauteng for diabetes treatment and responds well to standard medication. Her sister is treated for the same condition at a nearby facility, and despite identical diagnoses and treatments, their outcomes diverge sharply. In South Africa’s overstretched health system, such differences are common and point to a deeper issue: how biology is shaped by both genetic inheritance and experience.
South Africa’s diversity is often framed culturally and politically, but it is also biological. The population reflects some of the oldest human lineages, shaped by centuries of migration and admixture across African, European, Asian and other ancestries. This genetic variation is further shaped by unequal exposure to environmental and social factors, such as nutrition, infectious disease, pollution and access to healthcare, all of which influence health outcomes.
Much of modern biomedical knowledge is based on studies conducted in relatively genetically homogeneous populations in Europe and North America. While these have enabled major medical advances, findings do not always translate directly to South African contexts. Genetic risk variants and treatment responses observed in one population may differ in another, highlighting a gap between global knowledge and local reality.
“Our genetic diversity allows researchers to observe how the manifestation of diseases such as cancer, hypertension, diabetes and HIV is the result of multiple biological determinants, rather than a single one,” says Prof Pepper.
This has practical implications. South Africa faces a dual burden of infectious diseases like HIV and tuberculosis alongside rising non-communicable diseases such as cancer, cardiovascular disease and metabolic disorders. Many patients experience both, often compounded by socio-economic inequality. Understanding how genetics interacts with the environment (including infection) is essential for effective disease management.
At research centres such as the Institute for Cellular and Molecular Medicine, scientists are studying how genetic variation influences immune responses, cellular repair mechanisms and treatment outcomes.
“The aim is to advance precision medicine that works across diverse real-world populations, not just narrow genetic groups,” Prof Pepper says.
South Africa’s diversity also has global scientific value. Findings from its population can reveal disease mechanisms that remain hidden in more genetically uniform settings. In this way, local diversity becomes a source of international scientific insight and the common good.
Yet the impact of this research depends on inclusion. When diverse students, clinicians and researchers participate in science, the questions asked and interpretations made become more grounded in real-world contexts. This shapes not only what science discovers, but who it ultimately serves.
Why this research matters
South Africa’s healthcare system remains under strain, facing deep inequities and a growing burden of chronic disease. Yet within its population lies an underused scientific advantage: the ability to illuminate how disease truly behaves across human diversity. Recognising this does not simplify the country’s healthcare challenges, but it does offer a clearer lens through which to address them. In a system striving for equity, that perspective is not optional. It may be one of the most powerful tools we have. This research helps to address UN SDG 3: Good Health and Wellbeing.
This article first appeared in RE.SEARCH 15: Belonging. Read more here.
